About type 2-diabetes
Type 2 is a chronic disease. Find RYBELSUS® tips for living with and managing diabetes
The most common side effects observed in clinical trials were nausea, diarrhoea, and vomiting, with 15%, 10%, and 7% of patients, respectively, reporting one or more incidences. Most events were mild to moderate in severity and of short duration.1
You can learn more about potential side effects of treatment with
RYBELSUS® by reviewing the full package leaflet. You can
also contact your HCP if you want advice on how to manage side
effects.
Try to
Download the patient leaflet for more information about taking or using RYBELSUS®.
For questions about managing your diabetes and taking your daily RYBELSUS®, talk to your health care professional.
RYBELSUS® [summary of product characteristics]. Bagsværd, Denmark: Novo Nordisk A/S; REF- 53798; December 2021.
Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on
cardiovascular disease prevention in clinical practice. European Heart
Journal. 2016;37:2315–2381.
Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycaemia in type 2 diabetes, 2018. A Study of Diabetes (EASD). Diabetologia. 2018;61:2461–2498.
American Diabetes Association. Diabetes A to Z: What You Need to Know About Diabetes—Simply Put. 7th ed. Alexandria, VA: American Diabetes Association; 2016.